The Rising Influence of Rising Affluence

[DewDiligence]

MRNA invests $1B in China—unfettered by IP-theft risk:

https://www.yicaiglobal.com/news/20230705-02-us-vaccine-maker-moderna-to-make-first-investment-in-china-of-up-to-usd1-billion

Moderna is set to announce investment in China of as much as USD1 billion, the US vaccine maker’s first in the country, according to sources.

Chief Executive Stéphane Bancel has arrived in Shanghai and will attend the signing ceremony for the investment today, the sources told Yicai Global.

During a visit to the country in April, Bancel said…Moderna would accelerate its investment in Shanghai and join hands with its Chinese partners on research, development, and production.

Any drugs generated by this collaboration are intended for use by patients in China, not for export.

Good luck to MRNA in carrying this out without having its IP stolen.